{"name":"Zura Bio Inc","slug":"zura-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9STnhGQXBEMExzc21pQ0FsWWVYX0x4clFKNHpqdk1Dem5VUlhEaU15Z3lwM2NoVU1rcWtCdzI0Q1hnbmNBd09MNTRvTDY2NmtlVFNEdzR4eXU?oc=5","date":"2026-03-18","type":"pipeline","source":"White & Case LLP","summary":"Jessica Chen - White & Case LLP","headline":"Jessica Chen - White & Case LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQQXdPVW01ck9zbGdFSmU4LWpJTmM0dTEzR0x3ZFdFc2Fxc3FQaGdtNlNhSDJGNjdzV2tLNXhYeXFVb01vTHRRaUpWamZMRTh1YTFzSE5TcDIwYmUySzMxS3htSF95Ym5HSUhHNXlTQUdOOHdEWmtmZmZTNEVocTBuWTh3aDVzM1lk?oc=5","date":"2026-02-23","type":"pipeline","source":"Yahoo Finance","summary":"Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors - Yahoo Finance","headline":"Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Boar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPNER5RWlzY0NqVWhwbGVMdHVzcjZ0WjhpTkwxeVJNVTd1REwxeVd0ZkVLMFliY0x5SnVMR1Z3N2dwaThKMUo5MHdkeW1PZTJCY1pLclIwV19DOFUtemZlcUt5Nm5Ta2FZWTZXakc4OVpVVWc1a1JSM3VmdUF3S1M0TzI2ZlpodjRfSGlYSWFpRkxTY0JvYzZ1cE1PbVpLUndMUUNzMkFvZnFnZ1JQSFVfYVRmbWpOaXJPWXZEcDZWLWdReXJYRjBmRFZXQjRLMHFRSm05WDRB?oc=5","date":"2026-01-23","type":"pipeline","source":"Healio","summary":"Rheumatologists view CAR T-cell therapy as ‘revolutionary,’ but cost, safety temper enthusiasm - Healio","headline":"Rheumatologists view CAR T-cell therapy as ‘revolutionary,’ but cost, safety temper enthusiasm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNZVBHdEl1VDlFeFE3dndOQ0dlNGxhaTFldVc3c2VvMEZYXzgtQmhIeDc4RFRPRTdVZWJLaUtLeGFNd0JBbjhuajY5azN4d1lYY2plbkZrU09BSF90TFdVQS1TaEV2WXpSVmlldnQtcEc2OXJ4NFBpWUxnZE9xYUNPR3djWmQzSnBtRDJtTGpYVHB3WXRxOGN6b1YtNjBqcU1EU3l4Um9BMlNkUDVHRW9xY0lnd2piUHU3SVdQd21UVHlZZ1ItOHQ2X0JYUE9JSjlaempCaTQ1MHVEVjhDZ2pSemFza21VaW9NbEF0RUJ4MnNaNTh6UTIzY2R5ZUVPNmtNMU11dTgtUUtCUE15LU01NGljc19LVFFf?oc=5","date":"2026-01-21","type":"earnings","source":"Benzinga","summary":"Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks M - Benzinga","headline":"Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks M","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQR2FkZXM2MHZuWHJ1b2hub1RSQzVPWEpmdkJkWjgzQXFtYnI5VFNBR1pUNnhJY3hMWkg1eGthZW02T1NBLVpVWEIzd0J6WGdIQnZNWHpMZy11ZV9lMC11RWVQN3R2b0RjelJrWkhIQ002dklMcXhob3VZdlJlWWdZa2lySHlSRlZ1MjVzaEhlT1VITVVGdldEUkdnYnpBQzRuTDdnd0FzcksyWVNuTlJ0aUpaZDlUSEtGSjBGMV9TSHIyZS1DcktpaHNmT2JIR3JzVEN5TkVaOHE3bVhScmZQLWoyYlh1OXBPSVFZX0VSOG52RmYxVHFrSFB5OGdjNWVmbVdaajVqYmtraDdIRUx0NHB3?oc=5","date":"2025-12-29","type":"pipeline","source":"Benzinga","summary":"Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Mon - Benzinga","headline":"Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Mon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNbURGeFBVM19lWjJINGlwR01HamQ5X2traTA5bllxU0gyWkd6M21MeElyZXhHTzR2LUhvZ0tsbmNzZXVoVFp0bTc0a1pNZmxDaDFNTkxXT2RWNVpYZG5CZWpBYWNGNTVPVUVGQzJwYUY2YWpTb2hWMGJDSU5tUE9OMmlHOHNScHZDM3ZZRE5YXzFRTXZzT1BkYVFKWUlNN2g1YTh1aHJKN1h3eTJ2cTFFdzdVbnVHV05EWDQ0SVB6VEZDOFdkQzU2QUhyQXRXT3BmbDY0eDllY0R6LUhNaHo0dkU0dWtNUjJ5OGFteEdSUzM4SWlZVVRnX2ZDUWFMZmRKVmZXRllhZDNHN3QzLVRabWZERlhTV0JCTWdaQ1JUdmpqbkY5OHpNb053SUdRUQ?oc=5","date":"2025-10-23","type":"trial","source":"GlobeNewswire","summary":"Hidradenitis Suppurativa Clinical Trial Analysis: Key - GlobeNewswire","headline":"Hidradenitis Suppurativa Clinical Trial Analysis: Key","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-04","type":"pipeline","source":"simplywall.st","summary":"Does Zura Bio's (ZURA) Severance Plan Reflect Management's Priorities Amid Cash Burn Pressures? - simplywall.st","headline":"Does Zura Bio's (ZURA) Severance Plan Reflect Management's Priorities Amid Cash Burn Pressures?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE90WTN4VmdRWHU5X2hCVmRTTENCeGRseVEzbFlrenZ5cmlwelpGdFN3cHJMRGpNUldNb1Z4UllBSEFudUU1eXdfZmxGeG9IMEdkTWRFb3VPUUxzM0dfQjhzcV9Jakg?oc=5","date":"2024-06-30","type":"pipeline","source":"The Pharma Letter","summary":"Zura Bio - The Pharma Letter","headline":"Zura Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNWXNVU0p2MzdpOXJvdjMtVzZ2aXJZZnFzN0hXWGZ4bjcwdmZtV2NpOEM0MVJWNTFpMWI2c0dNbDdBcVBZQ0ZzNnZ1Q05kLVNnckdfWmxiSHdUYnFVV0tKZGt4cGxMRXJOTVBZUkxhLTh2QS16bDR1cXpVUUhUUUo2UnFVVHNsc1JqM3ZWVGYzZjdKdjFOOUFDWGR6dlR6UUp0QVBMOXJiYw?oc=5","date":"2024-04-08","type":"pipeline","source":"Contract Pharma","summary":"Zura Bio Names Robert Lisicki as CEO & Director of the Board - Contract Pharma","headline":"Zura Bio Names Robert Lisicki as CEO & Director of the Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxObXN3Q29fVGRManJDMHNuVFBzaGRENGZZQjMyc212RUpQN29iSWc5cGtnMWVzaGJxU09ISjE2Vm9fQVZ4ZTJNMUhtYnY3dnVfd3RTVW9JRlhKQU5OeEFYcU9tdEtlQ1l0Qnh2U0JZU1F2OXZiMzhBMmlmVzc2a3d0MFRBdXNZcEpMbWRFN09wb2piUXlHRkl4TU9oZ2VmMnR6SHM4aXctYm9xZ1d4aDVN?oc=5","date":"2024-04-08","type":"pipeline","source":"businesswire.com","summary":"Zura Bio Announces Robert Lisicki as CEO and Director - businesswire.com","headline":"Zura Bio Announces Robert Lisicki as CEO and Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5rYWpXOHFWdWIzWEtHQVgtdXFFcENZdFQ1UWMzQXMtRGFoaThVZlRRXzNtallWRDFQRlVGT1RaWElfSV9TX2ZGZk5ndGpXZHdjQkdZNGxRSktPM1dLQVlHS0hSUmpVaVRQTDJmTHRR?oc=5","date":"2023-05-25","type":"pipeline","source":"MarketBeat","summary":"Zura Bio (ZURA) Short Interest & Short Float | Updated Apr 2026 - MarketBeat","headline":"Zura Bio (ZURA) Short Interest & Short Float | Updated Apr 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOdlV4UW92TFhGQk9ZQ0JDa3ZqRHBBQTR4ZHg1Si1QTnljS25LZUJQN2xiUldXT19McGdMNjduc2lPRmNQQTIxcXJwWnJTaERiUlJnVnNuX2tuZVNBVW9wT2JCaWpLMURXWndOazNOZTgtTlM3X2o2T05UM09FaHkzQ28xVlNLdTdVT2pxa1hIb1pYWS1lOTZfb2g0NFN3OEZGbHR5amkxVQ?oc=5","date":"2022-06-17","type":"trial","source":"Fierce Biotech","summary":"Back to SPAC: Zura Bio opts for blank-check route to fund Pfizer drug into phase 2 - Fierce Biotech","headline":"Back to SPAC: Zura Bio opts for blank-check route to fund Pfizer drug into phase 2","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}